Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 6/2018

06.04.2018 | Head and Neck

Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review

verfasst von: Takenori Ogawa, Ikuho Kojima, Ryo Ishii, Maya Sakamoto, Takaki Murata, Takahiro Suzuki, Kengo Kato, Ayako Nakanome, Akira Ohkoshi, Eiichi Ishida, Seiji Kakehata, Kiyoto Shiga, Yukio Katori

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To improve the diagnoses of the salivary gland tumors, a dynamic-enhanced MRI (dMRI) was investigated.

Methods

We conducted a retrospective chart review of 93 cases of salivary gland tumors. The histological diagnoses were obtained from all patients using a surgical specimen and/or an open biopsy specimen. The dMRI as well as fine-needle aspiration cytology (FNAC) and intraoperative frozen section (IFS) were analyzed. This study focused on the time-intensity curve (TIC) after injection, peak time (Tpeak), washout ratio (WR) as well as the gradient of enhancement and washout profile.

Results

The histological diagnoses included pleomorphic adenoma (PMA) in 53 cases, the Warthin tumors (WT) in 14 cases and malignant tumors (MT) in 26 cases. Incorrect diagnosis rate of FNAC and IFS were 5.2 and 8.3%, respectively. The TIC revealed differences among the three types of tumors. Tpeak as well as WR also revealed significant differences (p < 0.001). Tpeak were lower in order of WT, MT, PMA, respectively. WR of TICs at 30, 45 and 105 s after Tpeak were higher in order of WT, MT, PMA, respectively (p < 0.001). The gradient of increment and washout in the TIC curve was also an important parameter to distinguish the three types of tumors. In MT, the rapid enhancement pattern was found in high or intermediate histological grade tumors, whereas the slow enhancement pattern was exhibited in low grade tumors.

Conclusions

Our findings indicate that using Tpeak and WR, it is possible to distinguish between WT, PMA and MT. Additionally, a rapid enhancement pattern may be a potential marker for these tumors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–138CrossRefPubMed Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–138CrossRefPubMed
2.
Zurück zum Zitat Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST (2008) Parotid tumors: a 10-year experience. Am J Otolaryngol 29:94–100CrossRefPubMed Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST (2008) Parotid tumors: a 10-year experience. Am J Otolaryngol 29:94–100CrossRefPubMed
3.
Zurück zum Zitat Brandwein-Gensier M, Bell D, Inagaki H et al (2017) Tumours of salivary glands. In: El-Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 160–202 Brandwein-Gensier M, Bell D, Inagaki H et al (2017) Tumours of salivary glands. In: El-Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 160–202
4.
Zurück zum Zitat Reddy VM, Thangarajah T, Castellanos-Arango F, Panarese A (2008) Conservative management of Warthin tumour. J Otolaryngol Head Neck Surg 37:744–749PubMed Reddy VM, Thangarajah T, Castellanos-Arango F, Panarese A (2008) Conservative management of Warthin tumour. J Otolaryngol Head Neck Surg 37:744–749PubMed
5.
Zurück zum Zitat Teymoortash A, Werner JA (2005) Tissue that has lost its track: Warthin’s tumour. Virchows Arch 446:585–588CrossRefPubMed Teymoortash A, Werner JA (2005) Tissue that has lost its track: Warthin’s tumour. Virchows Arch 446:585–588CrossRefPubMed
6.
Zurück zum Zitat Veder LL, Kerrebijn JD, Smedts FM, den Bakker MA (2010) Diagnostic accuracy of fine-needle aspiration cytology in Warthin tumors. Head Neck 32:1635–1640CrossRefPubMed Veder LL, Kerrebijn JD, Smedts FM, den Bakker MA (2010) Diagnostic accuracy of fine-needle aspiration cytology in Warthin tumors. Head Neck 32:1635–1640CrossRefPubMed
7.
Zurück zum Zitat Gudmundsson JK, Ajan A, Abtahi J (2016) The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci 24:561–567CrossRefPubMedPubMedCentral Gudmundsson JK, Ajan A, Abtahi J (2016) The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci 24:561–567CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ogawa T, Suzuki T, Sakamoto M et al (2012) Correct diagnosis of Warthin tumor in the parotid gland with dynamic MRI. Tohoku J Exp Med 227:53–57CrossRefPubMed Ogawa T, Suzuki T, Sakamoto M et al (2012) Correct diagnosis of Warthin tumor in the parotid gland with dynamic MRI. Tohoku J Exp Med 227:53–57CrossRefPubMed
9.
Zurück zum Zitat Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M (2008) Parotid gland tumors: can addition of diffusion-weighted mr imaging to dynamic contrast enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 249:909–916CrossRefPubMed Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M (2008) Parotid gland tumors: can addition of diffusion-weighted mr imaging to dynamic contrast enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 249:909–916CrossRefPubMed
10.
Zurück zum Zitat Yuan Y, Tang W, Tao X (2016) Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRI. Br J Radiol 89(1060):20150912CrossRefPubMedPubMedCentral Yuan Y, Tang W, Tao X (2016) Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRI. Br J Radiol 89(1060):20150912CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Stefanovic X, Al Tabaa Y, Gascou G et al (2017) Magnetic resonance imaging of parotid gland tumors: dynamic contrast-enhanced sequence evaluation. J Comput Assist Tomogr 41:541–546CrossRefPubMed Stefanovic X, Al Tabaa Y, Gascou G et al (2017) Magnetic resonance imaging of parotid gland tumors: dynamic contrast-enhanced sequence evaluation. J Comput Assist Tomogr 41:541–546CrossRefPubMed
12.
Zurück zum Zitat Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz C (2017) Diffusion- and perfusion-weighted magnetic resonance imaging—an alternative to fine needle biopsy or only an adjunct test in preoperative differential diagnostics of malignant and benign parotid tumors? J Oral Maxillofac Surg 75:2248–2253CrossRefPubMed Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz C (2017) Diffusion- and perfusion-weighted magnetic resonance imaging—an alternative to fine needle biopsy or only an adjunct test in preoperative differential diagnostics of malignant and benign parotid tumors? J Oral Maxillofac Surg 75:2248–2253CrossRefPubMed
13.
Zurück zum Zitat Eida S, Ohki M, Sumi M, Yamada T, Nakamura T (2008) MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors. J Magn Reson Imaging 27:1256–1262CrossRefPubMed Eida S, Ohki M, Sumi M, Yamada T, Nakamura T (2008) MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors. J Magn Reson Imaging 27:1256–1262CrossRefPubMed
14.
Zurück zum Zitat Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef
15.
Zurück zum Zitat Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echoplanar MR imaging. Radiology 220:621–630CrossRefPubMed Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echoplanar MR imaging. Radiology 220:621–630CrossRefPubMed
16.
Zurück zum Zitat Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M (2003) Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 226:345–354CrossRefPubMed Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M (2003) Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 226:345–354CrossRefPubMed
17.
Zurück zum Zitat Eida S, Sumi M, Sakihama N, Takahashi H, Nakamura T (2007) Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. Am J Neuroradiol 28:116–121PubMed Eida S, Sumi M, Sakihama N, Takahashi H, Nakamura T (2007) Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. Am J Neuroradiol 28:116–121PubMed
18.
Zurück zum Zitat Eida S, Sumi M, Nakamura T (2010) Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors. J Magn Reson Imaging 31:673–679CrossRefPubMed Eida S, Sumi M, Nakamura T (2010) Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors. J Magn Reson Imaging 31:673–679CrossRefPubMed
19.
Zurück zum Zitat Assili S, Fathi KA, Aghaghazvini L, Saligheh RHR, Pirayesh IJ (2015) Dynamic contrast magnetic resonance imaging (DCE-MRI) and diffusion weighted MR imaging (DWI) for differentiation between benign and malignant salivary gland tumors. J Biomed Phys Eng 5:157–168PubMedPubMedCentral Assili S, Fathi KA, Aghaghazvini L, Saligheh RHR, Pirayesh IJ (2015) Dynamic contrast magnetic resonance imaging (DCE-MRI) and diffusion weighted MR imaging (DWI) for differentiation between benign and malignant salivary gland tumors. J Biomed Phys Eng 5:157–168PubMedPubMedCentral
20.
Zurück zum Zitat Hisatomi M, Asaumi J, Yanagi Y et al (2007) Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors. Oral Oncol 43:940–947CrossRefPubMed Hisatomi M, Asaumi J, Yanagi Y et al (2007) Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors. Oral Oncol 43:940–947CrossRefPubMed
21.
Zurück zum Zitat Aghaghazvini L, Salahshour F, Yazdani N et al (2015) Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study. Dentomaxillofac Radiol 44:20140166CrossRefPubMed Aghaghazvini L, Salahshour F, Yazdani N et al (2015) Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study. Dentomaxillofac Radiol 44:20140166CrossRefPubMed
22.
Zurück zum Zitat Lam PD, Kuribayashi A, Imaizumi A et al (2015) Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. Br J Radiol 88(1049):20140685CrossRefPubMedPubMedCentral Lam PD, Kuribayashi A, Imaizumi A et al (2015) Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. Br J Radiol 88(1049):20140685CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Tao X, Yang G, Wang P et al (2017) The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours. Dentomaxillofac Radiol 46:20160434CrossRefPubMedPubMedCentral Tao X, Yang G, Wang P et al (2017) The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours. Dentomaxillofac Radiol 46:20160434CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Christe A, Waldherr C, Hallett R, Zbaeren P, Thoeny H (2011) MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease. Am J Neuroradiol 32:1202–1207CrossRefPubMed Christe A, Waldherr C, Hallett R, Zbaeren P, Thoeny H (2011) MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease. Am J Neuroradiol 32:1202–1207CrossRefPubMed
26.
Zurück zum Zitat Okahara M, Kiyosue H, Hori Y, Matsumoto A, Mori H, Yokoyama S (2003) Parotid tumors: MR imaging with pathological correlation. Eur Radiol 13(Suppl 4):L25–L33CrossRefPubMed Okahara M, Kiyosue H, Hori Y, Matsumoto A, Mori H, Yokoyama S (2003) Parotid tumors: MR imaging with pathological correlation. Eur Radiol 13(Suppl 4):L25–L33CrossRefPubMed
27.
Zurück zum Zitat Hisatomi M, Asaumi J, Konouchi H, Yanagi Y, Matsuzaki H, Kishi K (2002) Assessment of dynamic MRI of Warthin’s tumors arising as multiple lesions in the parotid glands. Oral Oncol 38:369–372CrossRefPubMed Hisatomi M, Asaumi J, Konouchi H, Yanagi Y, Matsuzaki H, Kishi K (2002) Assessment of dynamic MRI of Warthin’s tumors arising as multiple lesions in the parotid glands. Oral Oncol 38:369–372CrossRefPubMed
28.
Zurück zum Zitat Hisatomi M, Asaumi J, Yanagi Y et al (2003) Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI. Oral Oncol 39:574–579CrossRefPubMed Hisatomi M, Asaumi J, Yanagi Y et al (2003) Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI. Oral Oncol 39:574–579CrossRefPubMed
Metadaten
Titel
Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review
verfasst von
Takenori Ogawa
Ikuho Kojima
Ryo Ishii
Maya Sakamoto
Takaki Murata
Takahiro Suzuki
Kengo Kato
Ayako Nakanome
Akira Ohkoshi
Eiichi Ishida
Seiji Kakehata
Kiyoto Shiga
Yukio Katori
Publikationsdatum
06.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 6/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-4965-9

Weitere Artikel der Ausgabe 6/2018

European Archives of Oto-Rhino-Laryngology 6/2018 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.